Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



I have Alzheimer Disease

thiamine deficiency4 - neurodegenerative movement disorder1 - hippocampus6 - neocortex1 - berrios2 - initiative1 - trichloroethylene1 - amyloid plaques13 - clinical observations1 - mid-stage of alzheimer's1 - risk for dementia1 - marijuana1 - confabulatory euphoria1 - positron emission tomography3 - tau protein1 - thc1 - sleep tied to alzheimer's1 - huntington’s disease2 - thomas willis1 - ad prognosis1 - immune system1 - alcohol-related brain damage1 - dementiaantipsychotic drugs1 - sodium benzoate1 - igfbp-31 - disease progression1 - dat2 - pre-senile dementia1 - university of california2 - progressive movement disorder2 -